CD4分子(CD4)活性蛋白
Active Cluster Of Differentiation 4 (CD4)
CD4mut; p55; T-cell surface glycoprotein CD4; T-cell surface antigen T4/Leu-3
活性实验
Cluster of Differentiation 4 (CD4) is a transmembrane glycoprotein expressed primarily on helper T cells, regulatory T cells, and dendritic cells. As a key immune checkpoint molecule, it interacts with MHC class II molecules to modulate T cell activation, proliferation, and cytokine secretion, playing pivotal roles in adaptive immunity, inflammation, and immune homeostasis. CD4 binds to CXCR4, a G protein-coupled chemokine receptor, facilitating cell migration and signaling crosstalk in immune responses and tissue homeostasis.Briefly, CXCR4 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to CD4-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-CXCR4 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630nm immediately.Measured by its binding ability in a functional ELISA. When Recombinant CD4 is lmmobilized at 2 µg/mL(100 uLwell), the concentration of CXCR4 that produces 50% optimal bindingresponse is found to be approximately 3.97 µg/mL.
用法
PBS或其它。
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种:Rattus norvegicus (Rat,大鼠) | 应用(仅供研究使用,不用于临床诊断!) |
| EPB167Ra61 | CD4分子(CD4)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB167Ra61 | CD4分子(CD4)活性蛋白 | Cell culture; Activity Assays. |
| CPB167Ra21 | CD4分子(CD4)卵白蛋白偶联物 | Immunogen; SDS-PAGE; WB. |
参考文献
| 杂志 | 参考文献 |
| Taylor & Francis | Influences of Hyriopsis cumingii polysaccharides on mice immunosignaling molecules and T lymphocyte differentiation[09540105.2017.1306494] |
| anticancer research | Adjuvant Postoperative CD40 Agonist and PD-1 Antagonist Combination Therapy in Syngeneic Tongue Cancer Mouse Model[Pubmed: 32366416] |



